Nerivio® Drug-free Wearable Surpasses 100,000 Migraine Treatments in the US
Similar Posts
Cynerio Raises $30 Million in Series B Funding to Secure Mission-Critical Medical and IoT Devices in Hospitals and Health Systems
Funds will expand Cynerio’s US presence, with North American HQ in New York City, as well as its international…
Hospital Patient Visits Unlikely to Return
to Pre-COVID-19 Levels in 2021TransUnion Healthcare explores what’s ahead for healthcare utilization As the COVID-19 pandemic continues to weigh on the healthcare…
Saint Luke’s Health System Moves to the Innovaccer Health Cloud
Leading provider partners with Innovaccer to support value-based care initiatives that enhance network performance, improve patient engagement, and deliver…
Clearlake Capital-Backed nThrive Announces Name Change to FinThrive as Part of a Forthcoming Rebrand
New Company vision challenges the traditional approach from legacy incumbent solutions to revenue cycle management software and technology…
